Found: 14
Select item for more details and to access through your institution.
Predicting drug susceptibility of non-small cell lung cancers based on genetic lesions.
- Published in:
- 2009
- By:
- Publication type:
- journal article
Ferroptosis response segregates small cell lung cancer (SCLC) neuroendocrine subtypes.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-22336-4
- By:
- Publication type:
- Article
Ferroptosis response segregates small cell lung cancer (SCLC) neuroendocrine subtypes.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-22336-4
- By:
- Publication type:
- Article
A crucial requirement for Hedgehog signaling in small cell lung cancer.
- Published in:
- Nature Medicine, 2011, v. 17, n. 11, p. 1504, doi. 10.1038/nm.2473
- By:
- Publication type:
- Article
Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer.
- Published in:
- Nature Genetics, 2012, v. 44, n. 10, p. 1104, doi. 10.1038/ng.2396
- By:
- Publication type:
- Article
Analysis of Compound Synergy in High-Throughput Cellular Screens by Population-Based Lifetime Modeling.
- Published in:
- PLoS ONE, 2010, v. 5, n. 1, p. 1, doi. 10.1371/journal.pone.0008919
- By:
- Publication type:
- Article
Early Detection of Erlotinib Treatment Response in NSCLC by 3'-Deoxy-3'-[<sup>18</sup>F]-Fluoro-L-Thymidine ([<sup>18</sup>F]FLT) Positron Emission Tomography (PET).
- Published in:
- PLoS ONE, 2008, v. 3, n. 12, p. 1, doi. 10.1371/journal.pone.0003908
- By:
- Publication type:
- Article
MYC paralog-dependent apoptotic priming orchestrates a spectrum of vulnerabilities in small cell lung cancer.
- Published in:
- Nature Communications, 2019, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41467-019-11371-x
- By:
- Publication type:
- Article
AATF/Che-1 acts as a phosphorylation-dependent molecular modulator to repress p53-driven apoptosis.
- Published in:
- EMBO Journal, 2012, v. 31, n. 20, p. 3961, doi. 10.1038/emboj.2012.236
- By:
- Publication type:
- Article
Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1.
- Published in:
- Nature, 2009, v. 462, n. 7269, p. 108, doi. 10.1038/nature08460
- By:
- Publication type:
- Article
Sorafenib and everolimus in patients with advanced solid tumors and KRAS‐mutated NSCLC: A phase I trial with early pharmacodynamic FDG‐PET assessment.
- Published in:
- Cancer Medicine, 2020, v. 9, n. 14, p. 4991, doi. 10.1002/cam4.3131
- By:
- Publication type:
- Article
Optimization of Dosing for EGFR-Mutant Non-Small Cell Lung Cancer with Evolutionary Cancer Modeling.
- Published in:
- Science Translational Medicine, 2011, v. 3, n. 90, p. 1, doi. 10.1126/scitranslmed.3002356
- By:
- Publication type:
- Article
Frequent and Focal FGFR1 Amplification Associates with Therapeutically Tractable FGFR1 Dependency in Squamous Cell Lung Cancer.
- Published in:
- Science Translational Medicine, 2010, v. 2, n. 62, p. 1, doi. 10.1126/scitranslmed.3001451
- By:
- Publication type:
- Article
K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions.
- Published in:
- Nature, 2013, v. 503, n. 7477, p. 548, doi. 10.1038/nature12796
- By:
- Publication type:
- Article